000			04000nam a22003615i 4500
999			_c10569 _d10569
001			10569
003			ES-MaUEC
005			20210610170204.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			210226s2021 si | o |||| 0|eng d
020			_a9789813364042
024	7		_a10.1007/978-981-33-6404-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC360 _b.K87 2021 EB
245	0	0	_aMoyamoya Disease: Current Knowledge and Future Perspectives _cedited by Satoshi Kuroda
250			_a1st ed. 2021
264		1	_aCham _bSpringer Nature _c2021
300			_a1 recurso en línea (XV, 341 páginas) _b78 ilustraciones, 48 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF _2rda
505	0		_aPart I Concept of Moyamoya Disease -- 1 History of Disease Entity & Diagnosis Criteria -- 2 Moyamoya Syndrome -- 3 Unilateral Moyamoya Disease: A Distinct Entity? -- Part II Genetic Aspect of Moyamoya Disease -- 4 RNF213 as Susceptibility Gene -- 5 RNF213 and clinical feature -- 6 RNF213 Variant as a Biomarker of Cerebrovascular Disease -- Part III Pathophysiology of Moyamoya Disease -- 7 TIA & Headache in Pediatric Moyamoya Disease -- 8 Ischemic stroke -- 9 Hemorrhagic Stroke and the Japan Adult Moyamoya Trial -- 10 Cognitive Function in Pediatric Moyamoya Disease -- 11 Cognitive Dysfunction in Adults -- 12 Asymptomatic Moyamoya Disease -- Part IV Update on Neuroradiology in Moyamoya Disease -- 13 Periventricular Anastomosis -- 14 Arterial Shrinkage -- 15 Disease progression -- 16 Postoperative hyperperfusion -- 17 Postoperative FLAIR Imaging Changes -- Part V Real World of Surgical Revascularization for Moyamoya Disease -- 18 Overview of Surgical Revascularization and Long-term Outcome in Japan -- 19 Perioperative complications -- 20 Long-term Outcome in Europe -- 21 Long Term Outcomes in USA -- 22 Long-term Outcome in China -- 23 Long-term outcome of revascularization surgery for moyamoya disease in Korea -- 24 Indirect bypass surgery for moyamoya disease -- 25 Direct/combined bypass surgery -- 26 Special Considerations-Infants -- 27 Special Considerations - Elderly.
520	3		_aThis book brings together the latest knowledge on moyamoya disease, covering diagnostic criteria, status as a disease entity, genetic aspects, pathophysiology, novel neuroradiological findings, and surgical therapy. Information is also provided on recent basic and clinical research with the aim of identifying future perspectives on the disease. Since moyamoya disease was first reported in an English language article more than 50 years ago, our understanding of it has advanced considerably. Genetic and radiological analysis has delivered novel insights, and the latest multicenter studies are changing routine diagnosis and surgical therapy. The gene encoding the ring finger protein 213 (RNF213) has been identified as a susceptibility gene for moyamoya disease. Indications and procedures for surgical revascularization have been revised, with resultant improvements in outcomes, and studies performed over the past decade have provided new knowledge on the neuroradiological findings before and after surgery. In describing these advances, this book will be an invaluable asset for all general physicians, pediatricians, neurologists, radiologists, and neurosurgeons who care for patients with moyamoya disease across the world.
650		7	_2embne _9188115 _aSistema nervioso central _xEnfermedades
700	1		_aKuroda, Satoshi _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-33-6404-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI